HIPOLIN (HIPOLIN) Fair Value & Analysis

IN · Market cap ₹220M

H HIPOLIN HIPOLIN · BSE

Price₹70.38

Fair Value₹65.65

Upside-6.7%

Quality65/100

Watch HIPOLIN for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range ₹45.57 – ₹85.72

Fair value as of: Jul 5, 2026

From 7 valuation models · updated today

Share price −19.4% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹46.80 – ₹113.00 · fair‑value band ₹45.57 – ₹85.72 · the ₹70.38 price screens above the ₹65.65 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

HIPOLIN (HIPOLIN) currently trades at ₹70.38, while our model-based Fair Value estimate is ₹65.65 — implying the stock looks roughly 6.7% overvalued today. We read business quality at 65/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, HIPOLIN generated revenue of ₹141M at a net margin of -5.5%. Revenue declined 10.5% year over year. It earns a return on equity of -9.9%. Net debt stands at ₹4.0M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹45.57 (bear case) to ₹85.72 (bull case); at ₹70.38, the current price sits within that range. The share trades about 41% below its 52-week high and 57% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹141M

Revenue growth (YoY) -10.5%

Net margin -5.5%

Return on equity -9.9%

Free cash flow ₹16.1M FY2026

Operating margin -0.1%

More key figures

EPS (TTM) ₹-2.46

Net debt ₹4.0M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

HIPOLIN reported revenue of ₹141M in FY2026 versus ₹122M in FY2022, a compound +3.7%/yr. Reported net income was −₹7.7M in FY2026.

Revenue +3.7%/yr

FY22 ₹122M

FY23 ₹156M

FY24 ₹197M

FY25 ₹216M

FY26 ₹141M

Net income

FY22 −₹11.1M

FY23 ₹76.3M

FY24 −₹8.9M

FY25 −₹32.8M

FY26 −₹7.7M

Is HIPOLIN fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

HIPOLIN · Fair Value
₹65.65 −7%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/HIPOLIN" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">HIPOLIN · Fair Value</span><br><b style="font-size:20px">₹65.65</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−7%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "HIPOLIN Fair Value". https://www.fairvalue-calculator.com/stock/HIPOLIN

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is HIPOLIN (HIPOLIN) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹65.65 versus a price of ₹70.38 — about −7% (overvalued). Model-based estimate, not financial advice.

What is the fair value of HIPOLIN?

Our model-based fair value for HIPOLIN is ₹65.65 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹70.38.

What is the quality score of HIPOLIN?

HIPOLIN has a Quality Score of 65/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of HIPOLIN (HIPOLIN)?

HIPOLIN reported trailing-twelve-month revenue of about ₹141M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of HIPOLIN?

The net profit margin of HIPOLIN is about -5.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.